Mold-Tek Packaging Q1 FY27 Revenue Up 24.90% to ₹300.45 Crore
Mold-Tek Packaging reported a 24.90% YoY revenue growth to ₹300.45 crore in Q1 FY27. EBITDA increased by 19.11% to ₹56.43 crore, and PAT grew by 14.19% to ₹25.57 crore. Sales volume rose 6.25%. The company continues to focus on R&D and strategic consolidation for growth.
The results show positive growth, which is material for investors. However, it is a quarterly update and does not involve major corporate actions like mergers or acquisitions that would warrant a 'HIGH' impact.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, along with an increase in sales volume and EPS. Strategic initiatives like consolidation and focus on R&D are also highlighted.
Mold-Tek Packaging Limited announced its financial results for the first quarter ended June 30, 2026. The company reported a significant year-on-year revenue growth of 24.90%, reaching ₹300.45 crore compared to ₹240.55 crore in Q1 FY26. EBITDA saw a rise of 19.11% to ₹56.43 crore from ₹47.37 crore, while Profit After Tax (PAT) increased by 14.19% to ₹25.57 crore from ₹22.40 crore.
The company's sales volume grew by 6.25% to 12,089 MT from 11,378 MT in the same period. The Earnings Per Share (EPS) improved to ₹7.70 from ₹6.74, reflecting enhanced operational efficiency and cost control measures. The company highlighted strategic consolidation of its Hyderabad units, moving from 5 to 2 locations, which has unlocked EBIDTA expansion.
Key customer segments like Paints, Food, and Pharma showed strong performance. Paints revenue increased by 10.82% to ₹139 crore, Food by 26% to ₹66 crore, and Pharma by 39% to ₹9.26 crore. The company also emphasized its continued focus on R&D, new product development including metallized IML and innovative shapes, and automation through camera inspection and AI, positioning itself as an agile, innovation-driven, and sustainable packaging partner.
What to do with a filing like this
Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.